IBD (IBD) Stock Price & Analysis
IBD (IBD) rose 0.28% to USD 23.57 as of July 25, 2026 at 19:02 UTC, according to Nexqual real-time market data.
IBD last closed at USD 23.5; the session ranged USD 22.94–23.61 on volume of 136,137 shares. Market capitalization is —, with a 52-week range of USD 22.94–24.85 (PCX). Source: Nexqual, July 25, 2026 at 19:02 UTC.
Key Statistics (as of July 25, 2026 at 19:02 UTC)
| Price | USD 23.57 |
|---|---|
| Change | ▲ 0.28% (up) |
| Previous Close | USD 23.5 |
| Open | USD 23.53 |
| Day Range | USD 22.94 – 23.61 |
| 52-Week Range | USD 22.94 – 24.85 |
| Volume | 136,137 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IBD)
Nexqual's technical model rates IBD "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 19:02 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.59 (neutral) |
| vs SMA50 | Below (USD 23.76) |
| MACD | -0.04 (negative) |
Financial Health Score (IBD)
Nexqual rates IBD's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 19:02 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ISMD | Inspire Small/Mid Cap ETF | USD 48.97 | ▼ 0.77% |
| BLES | Inspire Global Hope ETF | USD 47.99 | ▼ 0.15% |
| BIBL | Inspire 100 ETF | USD 55.62 | ▲ 0.18% |
| WWJD | Inspire International ETF | USD 38.69 | ▼ 1.02% |
| RISN | Inspire Capital Appreciation ET | USD 30.86 | ▼ 0.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 19:02 UTC. This page is informational and not investment advice.